1,493
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

Repurposing levocetirizine hydrochloride loaded into cationic ceramide/phospholipid composite (CCPCs) for management of alopecia: central composite design optimization, in- silico and in-vivo studies

, , , , , & show all
Pages 2784-2795 | Received 22 Jun 2022, Accepted 25 Jul 2022, Published online: 01 Sep 2022

References

  • Abd-Elsalam WH, El-Helaly SN, Ahmed MA, Al-mahallawi AM. (2018). Preparation of novel phospholipid-based sonocomplexes for improved intestinal permeability of rosuvastatin: in vitro characterization, dynamic simulation, Caco-2 cell line permeation and in vivo assessment studies. Int. J. Pharm 548:375–84.
  • Abdelgawad R, Nasr M, Moftah NH, Hamza MY. (2017). Phospholipid membrane tubulation using ceramide doping “Cerosomes”: characterization and clinical application in psoriasis treatment. Eur J Pharm Sci 101:258–68.
  • Abdellatif MM, Khalil IA, Khalil MAF. (2017). Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: in-vitro, ex-vivo and in-vivo evaluation. Int J Pharm 527:1–11.
  • Albash R, El-Nabarawi MA, Refai H, Abdelbary AA. (2019). Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in vitro characterization, ex-vivo permeation and in-vivo assessment. Int J Nanomedicine 14:6555–74.
  • Albash R, Fahmy AM, Hamed MIA, et al. (2021a). Spironolactone hyaluronic acid enriched cerosomes (HAECs) for topical management of hirsutism: in silico studies, statistical optimization, ex vivo, and in vivo studies, Drug Deliv 28:2289–300.
  • Albash R, Yousry C, Al-Mahallawi AM, Alaa-Eldin AA. (2021b). Utilization of PEGylated cerosomes for effective topical delivery of fenticonazole nitrate: in-vitro characterization, statistical optimization, and in-vivo assessment. Drug Deliv 28:1–9.
  • Albash R, Al-mahallawi AM, Hassan M, Alaa-Eldin AA. (2021c). Development and optimization of terpene-enriched vesicles (terpesomes) for effective ocular delivery of fenticonazole nitrate: in vitro characterization and in vivo assessment. Int J Nanomedicine 16:609–21.
  • Albash R, Abdellatif MM, Hassan M, Badawi NM. (2021d). Tailoring terpesomes and leciplex for the effective ocular conveyance of moxifloxacin hydrochloride (comparative assessment): in-vitro, ex-vivo, and in-vivo evaluation. Int J Nanomedicine 16:5247–63.
  • Albash R, Ragaie MH, Hassab MAE, et al. (2022). Fenticonazole nitrate loaded trans-novasomes for effective management of tinea corporis : design characterization, in silico study, and exploratory clinical appraisal. Drug Deliv 29:1100–11.
  • Albuquerque SO, Barros TG, Dias LRS, et al. (2020). Biological evaluation and molecular modeling of peptidomimetic compounds as inhibitors for O-GlcNAc transferase (OGT). Eur J Pharm Sci 154:105510.
  • Amelian A, Wasilewska K, Wesoły M, et al. (2017). Taste-masking assessment of orally disintegrating tablets and lyophilisates with cetirizine dihydrochloride microparticles. Saudi Pharm J 25:1144–50.
  • Arayne MS, Sultana N, Nawaz M. (2008). Simultaneous quantification of cefpirome and cetirizine or levocetirizine in pharmaceutical formulations and human plasma by RP-HPLC. J Anal Chem 63:881–7.
  • Arias-Santiago S, Arrabal-Polo MA, Buenda-Eisman A, et al. (2012). Androgenetic alopecia as an early marker of benign prostatic hyperplasia. J AM Acad Dermatol 66:401–8.
  • Asasutjarit R, Lorenzen S-I, Sirivichayakul S, et al. (2007). Effect of solid lipid nanoparticles formulation compositions on their size. Pharm Res 24:1098–107.
  • Bender J, Ericson MB, Merclin N, et al. (2005). Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J Control Release 106:350–60.
  • Berrin K, Asuman B. (2017). Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells. Drug Dev. Ind. Pharm 44:1520–5762.
  • Castro BM, Prieto M, Silva LC. (2014). Ceramide: a simple sphingolipid with unique biophysical properties. Prog Lipid Res 54:53–67.
  • Dena ASA, Gaber SAA. (2017). In vitro drug interaction of levocetirizine and diclofenac: theoretical and spectroscopic studies. Spectrochim. Acta Part A Mol. Biomol. Spectrosc 181:239–48.
  • El-Dahmy RM, Elsayed I, Elshafeey AH, et al. (2014). Optimization of long circulating mixed polymeric micelles containing vinpocetine using simple lattice mixture design, in vitro and in vivo characterization. Int J Pharm 477:39–46.
  • El-dahmy RM, Hassen A, Abdelaziz N, et al. (2021). Statistical optimization of nanostructured gels for enhancement of vinpocetine transnasal and transdermal permeation. J. Drug Deliv. Sci. Technol 66:102871.
  • Elshafeey AH, El-dahmy RM. (2021). Formulation and development of oral fast-dissolving films loaded with nanosuspension to augment paroxetine bioavailability : in vitro characterization, ex vivo permeation, and pharmacokinetic evaluation in healthy human volunteers. Pharmaceutics 13:1869. [Preprint].
  • Fahmy AM, Hassan M, El-Setouhy DA, et al. (2021). Statistical optimization of hyaluronic acid enriched ultradeformable elastosomes for ocular delivery of voriconazole via Box-Behnken design : in vitro characterization and in vivo evaluation for ocular delivery of voriconazole via Box-Behnken design : in vitro. Drug Deliv 28:77–86.
  • Finner AM. (2011). Alopecia areata: clinical presentation, diagnosis, and. Dermatol Ther 24:348–54.
  • Goindi S, Kumar G, Kaur A. (2014). Novel flexible vesicles based topical formulation of levocetirizine: in vivo evaluation using oxazolone-induced atopic dermatitis in murine model. J Liposome Res 24:249–57.
  • Imam SS, Aqil M, Akhtar M, et al. (2015). Formulation by design-based proniosome for accentuated transdermal delivery of risperidone : in vitro characterization and in vivo pharmacokinetic study. Drug Deliv 22:1059–70.
  • Imam SS, Ahad A, Aqil M, et al. (2017). Formulation by design based risperidone nano soft lipid vesicle as a new strategy for enhanced transdermal drug delivery: in-vitro characterization, and in-vivo appraisal Syed. Mater Sci Eng C Mater Biol Appl 75:1198–205.
  • Jeong K, Ho JH, Jung ID, JEK, HK. (2018). Prostaglandin D2-mediated DP2 and AKT signal regulate the activation of androgen receptors in human dermal papilla cells. Int. J. Mol. Sci 2:1–12.
  • Oh EK, Jin S-E, Kim J-K, et al. (2011). Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy. Eur J Pharm Sci 44:149–57.
  • Kanei A, Asano K, Kanai K, Furuta A. (2014). Inhibitory action of levocetirizine on the production of eosinophil chemoattractants RANTES and eotaxin in vitro and in vivo. In Vivo (Brooklyn) 28:657–66.
  • Kasetvatin C, Rujivipat S, Tiyaboonchai W. (2015). Combination of elastic liposomes and low frequency ultrasound for skin permeation enhancement of hyaluronic acid. Colloids Surf B Biointerfaces 135:458–64.
  • Lin H, Xie Q, Huang X, et al. (2018). Increased skin permeation efficiency of imperatorin via charged ultradeformable lipid vesicles for transdermal delivery. IJN 13:831–42.
  • Madani S, Shapiro J. (2000). Alopecia areata update. J Am Acad Dermatol 42:549–66.
  • Farag MM, Abd El Malak NS, Yehia SA, Ahmed MA. (2021). Hyaluronic acid conjugated metformin-phospholipid sonocomplex : a biphasic complexation approach to correct hypoxic tumour microenvironment. Int J Nanomedicine 16:1005–19.
  • Rambwawasvika H, Dzomba P, Gwatidzo L. (2021). Alopecia types, current and future treatment. JDC 5:93–9.
  • Rossi A, Campo D, Fortuna MC, et al. (2018). A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia. J Dermatolog Treat 29:149–51.
  • de Souza AS, Pacheco BDC, Pinheiro S, et al. (2019). 3-Acyltetramic acids as a novel class of inhibitors for human kallikreins 5 and 7. Bioorg Med Chem Lett 29:1094–8.
  • Sun X, Zhang Z. (2004). Optimizing the novel formulation of liposome-polycation-DNA complexes (LPD) by central composite design. Arch Pharm Res 27:797–805.
  • Tran TH, Choi JY, Ramasamy T, et al. (2014). Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells. Carbohydr. Polym 114:407–15.
  • Vilar S, Cozza G, Moro S. (2008). Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem 8:1555–72.
  • Wen S, Wei J, Bao J, et al. (2020). Effect of levocetirizine hydrochloride on the growth of human dermal papilla cells : a preliminary study. Ann Palliat Med 9:308–17.
  • Xie J, Ji Y, Xue W, et al. (2018). Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery. Colloids Surf B Biointerfaces 172:323–9.